
| 2018 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Total Project Funding per Partner: | > 1000 |
| Total Number of Projects: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
| 2016 | |
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 4
As coordinator: 0
As participant: 4
Sole participant: 0
Coordinator / Participant Ratio: 0*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2023 | 0 | 6.771.571 | 0 | 1 | ||
| 2018 | 0 | 4.075.132 | 303.173 | 1 | ||
| 2017 | 0 | 3.933.617 | 273.288 | 1 | ||
| 2016 | 0 | 1.552.846 | 546.576 | 1 | ||
Total number of partners: 35
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 35
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2023-01-01 | GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION | GlycanTrigger | participant | 6.771.571 | 9 |
| 2018-10-01 | Glyco-Nanoparticles for Applications in Advance Nanomedicine | NanoCarb | participant | 4.075.132 | 16 |
| 2017-10-01 | Analytics for Biologics | A4B | participant | 3.933.617 | 11 |
| 2016-10-01 | Exploitation of Glycosylation Signatures for Precision Medicine | GlySign | participant | 1.552.846 | 3 |